June 2, 2025

Globally, head and neck cancer cases are on the rise, with smoking identified as a leading risk factor. These cancers encompass malignancies in areas such as the mouth, tongue, gums, throat, nasal cavity, and sinuses. https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/head-and-neck-cancer-is-rising-fast-smoking-could-be-the-reason/articleshow/121435686.cms?utm_source=chatgpt.com Additionally, the human papillomavirus (HPV) has been increasingly linked to throat cancers, particularly oropharyngeal cancers. Studies indicate that men,

A significant advancement in treating head and neck cancers, including throat cancer, has emerged from the international phase III KEYNOTE-689 trial. The study demonstrated that administering the immunotherapy drug pembrolizumab (Keytruda) both before and after surgery, alongside standard treatments like radiotherapy and chemotherapy, extended the average cancer-free period from 2.5 years to 5 years. This